Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 652 is a transcription factor that acts as a DNA-binding transcriptional repressor, predicted to regulate transcription by RNA polymerase II and to be localized in the nucleus. It has been associated with diseases including prostate cancer, and studies suggest roles in the regulation of cell proliferation and migration in cancer contexts. There is no evidence that ZNF652 is currently a direct therapeutic target, nor are specific drugs or clinical biomarkers known to interact with or utilize ZNF652 for patient selection or efficacy monitoring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 652 (ZNF652).